Keywords: sales, boost, synthelabo, france, rose, billion, french
14% SALES BOOST FOR SYNTHELABO
Article | 14 February 1994
Sales of France's Synthelabo for 1993 rose 13.9% to 7.2 billion French francs ($1.22 billion) compared with the previous year. On a comparable basis, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
